Related Experiment Videos
Platelet-activating factor antagonists and implantation in rabbits
C J Norris1, W A Peairs, G B Kudolo
1Department of Obstetrics and Gynecology, University of Texas Health Science Center, San Antonio 78284-7836.
Journal of Reproduction and Fertility
|March 1, 1994
Summary
Platelet-activating factor (PAF) antagonists were tested for their effect on rabbit implantation. Results showed no clear evidence that PAF plays a role in this process.
Area of Science:
- Reproductive Biology
- Pharmacology
Background:
- Platelet-activating factor (PAF) is a lipid mediator implicated in various physiological processes.
- The potential role of PAF in embryo implantation requires further investigation.
Purpose of the Study:
- To evaluate the effect of PAF antagonists on implantation in a rabbit model.
- To determine if inhibiting PAF signaling impacts the success of embryo implantation.
Main Methods:
- Rabbits were administered various PAF antagonists, including CV-3988, N-carbamyl-PAF (C-PAF), BN52021, SRI63,441, WEB2086, and TCV-309.
- Drug administration occurred during critical periods of early pregnancy (days 2-6).
- Implantation success was assessed following antagonist treatment.
Main Results:
- Initial experiments showed transient inhibition of implantation with CV-3988, which was not reproducible.
- N-carbamyl-PAF (C-PAF) only inhibited implantation at toxic doses.
- Combinations of CV-3988 and C-PAF, and other tested PAF antagonists (BN52021, SRI63,441, WEB2086, TCV-309), did not affect implantation rates.
Conclusions:
- The tested PAF antagonists, administered during early pregnancy in rabbits, did not consistently inhibit implantation.
- These findings suggest that PAF may not play a critical role in the process of implantation in this species.